CPR8 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-10594
Key Product Details
Species Reactivity
Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Rat CPR8 (NP_001102240). Peptide sequence HKEKIKQAKEAVKENLKKFSDSVKSTFRHFKDTTKNIFDEKGSKRFRASK
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
69 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for CPR8 Antibody
Western Blot: CPR8 Antibody [NBP3-10594]
Western Blot: CPR8 Antibody [NBP3-10594] - Western blot analysis of CPR8 in Rat Stomach lysates. Antibody dilution at 1.0ug/mlApplications for CPR8 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CPR8
Alternate Names
CCP8, cell cycle progression 1, cell cycle progression protein 1, cell cycle progression restoration protein 8, CPR8, FLJ60574, KIAA1254
Gene Symbol
CCPG1
Additional CPR8 Products
Product Specific Notices for CPR8 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...